NCT05838391 2026-02-03
Adaptive Radiation in Anal Cancer
Columbia University
Phase NA Recruiting
Clinical Trials
13 trialsNCT03519295 2025-06-27
SCARCE
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Completed
NCT02199236 2024-11-01
Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT03018418 2024-09-19
Proton Therapy in Reducing Toxicity in Anal Cancer
University of Cincinnati
Phase 2 Active not recruiting
NCT04230759 2024-09-19
RADIANCE
Goethe University
Phase 2 Active not recruiting
NCT03690921 2023-06-29
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00003652 2021-02-17
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
UNICANCER
Phase 3 Completed
NCT01671488 2020-02-17
276
Brown University
Phase 1/2 Terminated
NCT04269369 2020-02-13
Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients
Jessa Hospital
Phase 4 Unknown
NCT01285778 2018-05-16
VITAL
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2 Completed
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT00654160 2017-05-25
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Mayo Clinic
Phase 1 Completed
NCT02051868 2015-11-04
InterAACT
Royal Marsden NHS Foundation Trust
Phase 2 Unknown